Business Description
Clover Health Investments Corp
NAICS : 525120
SIC : 6324
ISIN : US18914F1030
Description
Financial Strength
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 94.53 | |||||
Equity-to-Asset | 0.48 | |||||
Debt-to-Equity | 0.01 | |||||
Debt-to-EBITDA | -0.03 | |||||
Interest Coverage | N/A | |||||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | 1.24 | |||||
Beneish M-Score | -2.76 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 36.3 | |||||
3-Year EBITDA Growth Rate | -30.9 | |||||
3-Year EPS without NRI Growth Rate | -0.5 | |||||
3-Year FCF Growth Rate | 6.4 | |||||
Future 3-5Y EPS without NRI Growth Rate Estimate | 31.46 |
Momentum Rank
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 61.43 | |||||
9-Day RSI | 60.54 | |||||
14-Day RSI | 61.7 | |||||
6-1 Month Momentum % | 347.62 | |||||
12-1 Month Momentum % | 195.81 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 1.69 | |||||
Quick Ratio | 1.69 | |||||
Cash Ratio | 1.17 | |||||
Days Payable | 9.95 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -6.5 | |||||
Shareholder Yield % | 0.77 |
Profitability Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 18.58 | |||||
Operating Margin % | -6.05 | |||||
Net Margin % | -7.3 | |||||
FCF Margin % | -10.51 | |||||
ROE % | -39.75 | |||||
ROA % | -14.61 | |||||
ROIC % | -30.08 | |||||
3-Year ROIIC % | -147.53 | |||||
ROC (Joel Greenblatt) % | -1527.64 | |||||
ROCE % | -38.15 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 1.2 | |||||
PB Ratio | 6.18 | |||||
Price-to-Tangible-Book | 6.23 | |||||
EV-to-EBIT | -12.88 | |||||
EV-to-Forward-EBIT | 84.54 | |||||
EV-to-EBITDA | -13.07 | |||||
EV-to-Forward-EBITDA | -74.12 | |||||
EV-to-Revenue | 0.97 | |||||
EV-to-Forward-Revenue | 1.07 | |||||
EV-to-FCF | -9.19 | |||||
Price-to-Net-Current-Asset-Value | 10.13 | |||||
Price-to-Net-Cash | 67.42 | |||||
Earnings Yield (Greenblatt) % | -7.76 | |||||
FCF Yield % | -8.86 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:CLOV
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Clover Health Investments Corp Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil $) | 1,695.499 | ||
EPS (TTM) ($) | -0.266 | ||
Beta | 2.41 | ||
Volatility % | 101.38 | ||
14-Day RSI | 61.7 | ||
14-Day ATR ($) | 0.247895 | ||
20-Day SMA ($) | 3.98575 | ||
12-1 Month Momentum % | 195.81 | ||
52-Week Range ($) | 0.606 - 4.71 | ||
Shares Outstanding (Mil) | 497.47 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 4 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Clover Health Investments Corp Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Clover Health Investments Corp Stock Events
Event | Date | Price($) | ||
---|---|---|---|---|
No Event Data |
Clover Health Investments Corp Frequently Asked Questions
What is Clover Health Investments Corp(CLOV)'s stock price today?
When is next earnings date of Clover Health Investments Corp(CLOV)?
Does Clover Health Investments Corp(CLOV) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |